← X-Energy, Inc. Class A Common Stock overview

X-Energy, Inc. Class A Common Stock vs BWX: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

X-Energy, Inc. Class A Common Stock (XE)

Q3 202624 Jun – 23 Sep 2026

▲3▼1

X-Energy's first reactor delayed to 2027, but capital-light model and funding advance

First reactor delayed to 2027 after regulatory setback X-Energy's first Amazon reactor slipped to 2027 after regulators failed to approve its design, prompting a Jefferies downgrade and a 19.2% weekly stock drop. For a pre-revenue company, this is a serious setback.
This was the biggest negative event of the quarter and directly caused a sharp stock decline.
Capital-light licensing and fuel sales model advanced X-Energy advanced a capital-light model, licensing its Xe-100 reactor and selling TRISO-X fuel, avoiding construction costs while creating recurring revenue. This reduces cash burn and could improve long-term profitability.
This strategic shift is a key positive development that could drive future value.
Secured $11M grant and up to $1B additional DOE funding X-Energy won an $11M Tennessee grant to expand fuel capacity and gained up to $1B in additional DOE funding (total $2.115B, with $1.9B cash and no debt). This strengthens its financial position.
These funding wins provide crucial capital and validate government support.
Entered UK safety review and AI-nuclear partnerships X-Energy entered the UK safety review and joined AI-nuclear partnerships with Microsoft and Nvidia. Ark Invest, Peter Thiel, Jane Street, and Amazon invested, though UK approval remains years away and uncertain.
These partnerships and investments signal confidence but come with long-term uncertainty.

August 202621 Jul – 23 Sep 2026

▲4

X-Energy gains on AI-nuclear deals, funding, and global expansion

AI-nuclear partnerships X-Energy joined a Trump administration AI-nuclear program with Microsoft and Nvidia, and became a Tier 1 partner in the $60M Prometheus project, linking its reactors to power-hungry AI data centers.
This new partnership highlights X-Energy's central role in the AI data center boom, a key growth driver.
DOE funding boost X-Energy secured up to $1B in additional DOE funding, raising its total cost share to $2.115B. With $1.9B cash and zero debt, it is well-funded to execute its plans.
This new funding strengthens X-Energy's financial position and supports its capital-intensive projects.
UK safety review entry X-Energy entered the UK's safety review for its Xe-100 reactor, targeting up to 6 GW of deployment. This opens a new market but approval is years away and not guaranteed.
This new international expansion signals long-term growth potential, though with regulatory uncertainty.
High-profile investments Peter Thiel, Jane Street, and Amazon invested in X-Energy, signaling confidence. However, disclosed fund stakes are backward-looking and can change, indicating interest rather than certainty.
These new investments from notable figures and firms can boost market sentiment, though they are not guarantees.

Latest4 Aug – 23 Sep 2026

▲4

X-Energy advances fuel, AI design, UK review; big funds buy in

Fuel campus expansion backs reactor buildout TRISO-X, X-Energy's fuel arm, bought about 70 more acres at its Oak Ridge, Tennessee site, bringing it to roughly 180 acres. More room for fuel storage and future plants supports the fuel supply its reactors need, a step toward actually delivering projects rather than just designing them.
Shows concrete progress on the fuel supply chain that underpins XE's reactor pipeline.
AI project aims to speed reactor design and licensing X-Energy joined Project Prometheus, a $60 million Department of Energy effort with Idaho National Laboratory, Nvidia and Amazon, putting in $10 million and its reactor data. Using AI to speed design and licensing could shorten the long delays that have historically hurt nuclear projects, helping its 144-reactor pipeline move faster.
Explains a new technology effort that could reduce execution risk on XE's pipeline.
UK regulator accepts Xe-100 for safety review Britain accepted X-Energy's Xe-100 reactor into its Generic Design Assessment, a roughly three-year safety review. With partner Centrica, X-Energy aims for up to 6 GW in the UK, and this opens a new market beyond its Dow and Amazon deals, though approval is years away and not guaranteed.
A new regulatory milestone that expands XE's addressable market and pipeline.
Big-name funds disclose new stakes in X-Energy Jane Street revealed a new roughly $70.8 million X-Energy stake, and Peter Thiel's Thiel Macro included it in a $418.67 million portfolio betting on AI power needs. Large investors buying can lift the shares, but these are second-quarter snapshots and can change, so they signal interest, not a guarantee.
New institutional buying is a direct capital-flow driver for XE shares.

21 Jul – 25 Aug 2026

▲4

X-Energy's AI power deals and $1B DOE boost drive growth story

Joins Trump AI-nuclear program X-Energy joined a $200 million Trump administration effort with Microsoft and Nvidia to speed nuclear reactors for AI data centers. This puts XE at the center of a national push to power AI, boosting demand for its reactors and lifting the stock.
This is a new, concrete government program that directly benefits XE's core business and investor perception.
Tier 1 partner in $60M Prometheus AI-nuclear project X-Energy became a Tier 1 partner in the Prometheus project, providing $10 million and its Xe-100 reactor and TRISO-X fuel designs. The AI-driven research aims to accelerate commercial deployment across its 11 GW pipeline, a clear positive for future revenue.
This is a new, specific partnership that advances XE's technology and pipeline, directly supporting the stock.
Up to $1B extra DOE funding and strong cash X-Energy announced up to $1 billion more from the DOE for its ARDP agreement, raising the DOE cost share to $2.115 billion. With $1.9 billion in cash, zero debt, and NRC permit expected by Q1 2027, the company is well-funded to execute.
This is a new, material funding update that strengthens XE's balance sheet and reduces financing risk.
Thiel bet and AI power bottleneck highlight Peter Thiel's fund disclosed a $3.7 million stake in X-Energy as part of a $418 million bet on AI's power bottleneck. Amazon's ~$500 million investment and XE's 11.5 GW pipeline underscore its role in solving AI's energy needs, drawing investor attention.
This is a new, high-profile endorsement that validates XE's demand thesis and could attract more investors.

July 202624 Jun – 15 Jul 2026

▲3▼1

X-Energy's capital-light nuclear fuel strategy gains traction after delay-driven selloff

First reactor delayed to 2027; Jefferies downgrade X-Energy's first Amazon reactor slipped to 2027 because U.S. regulators haven't approved its reactor design. Jefferies downgraded the stock and cut its price target from $30 to $22. The stock fell 19.2% that week, a real setback for a pre-revenue company.
This is the main negative force this period, explaining why the stock sold off and remains under pressure.
Capital-light licensing and fuel-sales model X-Energy is shifting to licensing its Xe-100 reactor design and selling TRISO-X fuel instead of building plants itself. This avoids huge construction costs and creates recurring fuel revenue over each reactor's 60-year life. Its fuel facility got the first U.S. license for commercial advanced fuel production.
This new strategy is the core reason investors can still see long-term value despite the delay.
Tennessee $11M grant expands fuel campus TRISO-X won an $11 million Tennessee grant to expand its Oak Ridge fuel campus, adding TX-2 and TX-L facilities. Together they could fuel about 55 Xe-100 reactors, nearly 4.5 gigawatts. This directly supports future reactor demand and shows government backing.
New government funding signals real progress on the fuel side, a fresh positive catalyst.
Ark Invest buys the dip, adding $15.4M Cathie Wood's Ark Invest bought more X-Energy shares on the dip, including a $15.4 million purchase the week of July 13. A well-known fund showing conviction can support the stock, though it doesn't change the company's delayed project timeline.
A notable investor's buying is a fresh signal of confidence, though it's a sentiment boost rather than a fundamental fix.

24 Jun – 15 Jul 2026

▲3▼1

X-Energy's capital-light nuclear fuel strategy gains traction after delay-driven selloff

First reactor delayed to 2027; Jefferies downgrade X-Energy's first Amazon reactor slipped to 2027 because U.S. regulators haven't approved its reactor design. Jefferies downgraded the stock and cut its price target from $30 to $22. The stock fell 19.2% that week, a real setback for a pre-revenue company.
This is the main negative force this period, explaining why the stock sold off and remains under pressure.
Capital-light licensing and fuel-sales model X-Energy is shifting to licensing its Xe-100 reactor design and selling TRISO-X fuel instead of building plants itself. This avoids huge construction costs and creates recurring fuel revenue over each reactor's 60-year life. Its fuel facility got the first U.S. license for commercial advanced fuel production.
This new strategy is the core reason investors can still see long-term value despite the delay.
Tennessee $11M grant expands fuel campus TRISO-X won an $11 million Tennessee grant to expand its Oak Ridge fuel campus, adding TX-2 and TX-L facilities. Together they could fuel about 55 Xe-100 reactors, nearly 4.5 gigawatts. This directly supports future reactor demand and shows government backing.
New government funding signals real progress on the fuel side, a fresh positive catalyst.
Ark Invest buys the dip, adding $15.4M Cathie Wood's Ark Invest bought more X-Energy shares on the dip, including a $15.4 million purchase the week of July 13. A well-known fund showing conviction can support the stock, though it doesn't change the company's delayed project timeline.
A notable investor's buying is a fresh signal of confidence, though it's a sentiment boost rather than a fundamental fix.

BWX Technologies Inc (BWXT)

Q3 202622 Jul – 5 Oct 2026

▲4

BWXT Q3: Guidance Raised, Backlog Surges, New Nuclear Deals

Guidance raised after strong Q2 results BWXT raised its full-year guidance after Q2 revenue rose 18% to $901.6 million and earnings per share beat estimates. This shows the company is performing better than expected and expects continued strength.
Guidance raise and earnings beat are key new positive developments that directly affect investor expectations.
Backlog jumps 39.6% to $8.4 billion BWXT's backlog surged 39.6% to $8.4 billion, indicating strong future revenue visibility. This growth reflects robust demand across its nuclear defense and commercial businesses.
Backlog growth is a critical indicator of future revenue and was not mentioned in earlier reports.
New contracts: Army microreactor and Canadian nuclear plant BWXT won a U.S. Army contract for the Janus microreactor and a deal for a Canadian transportable nuclear plant. These expand its footprint in mobile and small nuclear power.
These are new contract wins that open additional revenue streams and demonstrate BWXT's technological leadership.
First investment-grade rating and strategic portfolio moves BWXT secured its first investment-grade credit rating (BBB) and sold its medical unit for $800 million, sharpening focus on core nuclear operations. The Saudi 30-year nuclear pact also boosts long-term prospects.
These strategic actions improve financial flexibility and focus, supporting growth and shareholder value.

September 202626 Aug – 5 Oct 2026

▲4

BWXT Wins New Reactor Deals, Expands Capacity, Targets $6B Revenue by 2030

U.S. Army Janus Program Selection BWXT was chosen to deploy its BANR microreactor for the U.S. Army's Janus program, with the first unit planned at Fort Campbell. This is a major government contract that adds long-term revenue and validates BWXT's advanced reactor technology, pushing the stock up.
This is a new, significant contract win that directly boosts future demand and revenue visibility.
Manufacturing Expansion and Strong 2025 Revenue BWXT expanded its Cambridge, Ontario facility and is investing in uranium processing and advanced manufacturing. Its 2025 revenue rose 18.3% to $3.2 billion, with projected EPS growth ahead. This shows execution and capacity to meet rising nuclear demand, supporting the stock.
It highlights tangible growth and investment that underpin future earnings.
Inaugural Investment Grade Credit Rating Fitch gave BWXT its first investment grade rating of BBB with a stable outlook, citing its strong market position and cash flow. This lowers borrowing costs and signals financial health, which can attract more investors and lift the stock.
A new credit rating improves BWXT's financial profile and investor appeal.
Investor Day Targets and Canadian Microreactor Deal BWXT set 2030 revenue targets of $5.5–$6 billion, doubled its backlog to $8.4 billion, and is selling a non-core unit to fund nuclear growth. It also won a Canadian transportable nuclear plant project. These moves clarify long-term growth and add new demand, supporting the stock despite a recent pullback.
These are new strategic updates that directly address future growth and market opportunities.

Latest26 Aug – 5 Oct 2026

▲4

BWXT Wins New Reactor Deals, Expands Capacity, Targets $6B Revenue by 2030

U.S. Army Janus Program Selection BWXT was chosen to deploy its BANR microreactor for the U.S. Army's Janus program, with the first unit planned at Fort Campbell. This is a major government contract that adds long-term revenue and validates BWXT's advanced reactor technology, pushing the stock up.
This is a new, significant contract win that directly boosts future demand and revenue visibility.
Manufacturing Expansion and Strong 2025 Revenue BWXT expanded its Cambridge, Ontario facility and is investing in uranium processing and advanced manufacturing. Its 2025 revenue rose 18.3% to $3.2 billion, with projected EPS growth ahead. This shows execution and capacity to meet rising nuclear demand, supporting the stock.
It highlights tangible growth and investment that underpin future earnings.
Inaugural Investment Grade Credit Rating Fitch gave BWXT its first investment grade rating of BBB with a stable outlook, citing its strong market position and cash flow. This lowers borrowing costs and signals financial health, which can attract more investors and lift the stock.
A new credit rating improves BWXT's financial profile and investor appeal.
Investor Day Targets and Canadian Microreactor Deal BWXT set 2030 revenue targets of $5.5–$6 billion, doubled its backlog to $8.4 billion, and is selling a non-core unit to fund nuclear growth. It also won a Canadian transportable nuclear plant project. These moves clarify long-term growth and add new demand, supporting the stock despite a recent pullback.
These are new strategic updates that directly address future growth and market opportunities.

August 202622 Jul – 12 Aug 2026

▲4

BWXT Raises Guidance on Strong Q2 and Saudi Nuclear Deal

Saudi Nuclear Pact Opens New Market The U.S. and Saudi Arabia signed a 30-year civilian nuclear deal that favors American companies. BWXT, as a nuclear component and service provider, could win new contracts, boosting future revenue and profit.
This is a new, major demand driver that expands BWXT's addressable market.
Strong Q2 and Raised 2026 Guidance BWXT reported Q2 revenue of $901.6M (up 18%) and EPS of $1.07, beating estimates. It raised full-year EBITDA and EPS guidance, signaling confidence in continued growth.
This is the core financial update that directly lifts investor expectations and the stock price.
Medical Business Sale Sharpens Focus BWXT agreed to sell its medical unit for up to $800M, keeping a minority stake. The proceeds will fund core nuclear defense and commercial power, improving capital allocation and profitability.
This strategic move frees up capital and refocuses the company on higher-growth areas.
Backlog Surges 39.6% to $8.4B BWXT's backlog jumped to $8.40 billion, up 39.6% from last year, driven by strong government and commercial nuclear demand. This provides revenue visibility and supports future growth.
A record backlog is a key indicator of future sales and earnings power.

22 Jul – 12 Aug 2026

▲4

BWXT Raises Guidance on Strong Q2 and Saudi Nuclear Deal

Saudi Nuclear Pact Opens New Market The U.S. and Saudi Arabia signed a 30-year civilian nuclear deal that favors American companies. BWXT, as a nuclear component and service provider, could win new contracts, boosting future revenue and profit.
This is a new, major demand driver that expands BWXT's addressable market.
Strong Q2 and Raised 2026 Guidance BWXT reported Q2 revenue of $901.6M (up 18%) and EPS of $1.07, beating estimates. It raised full-year EBITDA and EPS guidance, signaling confidence in continued growth.
This is the core financial update that directly lifts investor expectations and the stock price.
Medical Business Sale Sharpens Focus BWXT agreed to sell its medical unit for up to $800M, keeping a minority stake. The proceeds will fund core nuclear defense and commercial power, improving capital allocation and profitability.
This strategic move frees up capital and refocuses the company on higher-growth areas.
Backlog Surges 39.6% to $8.4B BWXT's backlog jumped to $8.40 billion, up 39.6% from last year, driven by strong government and commercial nuclear demand. This provides revenue visibility and supports future growth.
A record backlog is a key indicator of future sales and earnings power.

Q2 202617 Jun – 7 Jul 2026

▲4

BWXT's nuclear growth accelerates on AI power demand and commercial expansion

mPower SMR licensing deal BWXT licensed its mPower small modular reactor technology to Applied Atomics, keeping exclusive manufacturing rights and royalties. This opens a new revenue stream from future SMR deployments, driven by rising electricity demand from data centers.
New licensing agreement directly adds a potential high-margin revenue stream and validates BWXT's technology.
Commercial revenue surges 121% BWXT's commercial nuclear segment revenue jumped 121% in Q1 2026 to $283.6 million, with backlog at $1.72 billion. This shows strong demand for its commercial nuclear components and services, boosting growth prospects.
Concrete financial data reveals a major growth driver that is new and directly impacts future earnings.
Analyst upgrades and price target hikes Seaport Research and Deutsche Bank upgraded BWXT to Buy with price targets of $245 and $255, citing strong results, higher guidance, and the Precision Components acquisition. Upgrades can attract more investors and lift the stock price.
New analyst actions reflect improving sentiment and can influence short-term demand for the stock.
Long-term material supply agreement with ATI BWXT signed a supply deal with ATI through fiscal 2030 for specialized materials used in naval nuclear propulsion. This secures critical inputs for its Navy programs, reducing supply risk and supporting steady production.
New agreement ensures supply chain stability for a key revenue segment, which is important for long-term growth.

June 202617 Jun – 7 Jul 2026

▲4

BWXT's nuclear growth accelerates on AI power demand and commercial expansion

mPower SMR licensing deal BWXT licensed its mPower small modular reactor technology to Applied Atomics, keeping exclusive manufacturing rights and royalties. This opens a new revenue stream from future SMR deployments, driven by rising electricity demand from data centers.
New licensing agreement directly adds a potential high-margin revenue stream and validates BWXT's technology.
Commercial revenue surges 121% BWXT's commercial nuclear segment revenue jumped 121% in Q1 2026 to $283.6 million, with backlog at $1.72 billion. This shows strong demand for its commercial nuclear components and services, boosting growth prospects.
Concrete financial data reveals a major growth driver that is new and directly impacts future earnings.
Analyst upgrades and price target hikes Seaport Research and Deutsche Bank upgraded BWXT to Buy with price targets of $245 and $255, citing strong results, higher guidance, and the Precision Components acquisition. Upgrades can attract more investors and lift the stock price.
New analyst actions reflect improving sentiment and can influence short-term demand for the stock.
Long-term material supply agreement with ATI BWXT signed a supply deal with ATI through fiscal 2030 for specialized materials used in naval nuclear propulsion. This secures critical inputs for its Navy programs, reducing supply risk and supporting steady production.
New agreement ensures supply chain stability for a key revenue segment, which is important for long-term growth.

17 Jun – 7 Jul 2026

▲4

BWXT's nuclear growth accelerates on AI power demand and commercial expansion

mPower SMR licensing deal BWXT licensed its mPower small modular reactor technology to Applied Atomics, keeping exclusive manufacturing rights and royalties. This opens a new revenue stream from future SMR deployments, driven by rising electricity demand from data centers.
New licensing agreement directly adds a potential high-margin revenue stream and validates BWXT's technology.
Commercial revenue surges 121% BWXT's commercial nuclear segment revenue jumped 121% in Q1 2026 to $283.6 million, with backlog at $1.72 billion. This shows strong demand for its commercial nuclear components and services, boosting growth prospects.
Concrete financial data reveals a major growth driver that is new and directly impacts future earnings.
Analyst upgrades and price target hikes Seaport Research and Deutsche Bank upgraded BWXT to Buy with price targets of $245 and $255, citing strong results, higher guidance, and the Precision Components acquisition. Upgrades can attract more investors and lift the stock price.
New analyst actions reflect improving sentiment and can influence short-term demand for the stock.
Long-term material supply agreement with ATI BWXT signed a supply deal with ATI through fiscal 2030 for specialized materials used in naval nuclear propulsion. This secures critical inputs for its Navy programs, reducing supply risk and supporting steady production.
New agreement ensures supply chain stability for a key revenue segment, which is important for long-term growth.